NCT01421212: Pilot Study to Assess the Pharmacokinetics of Intravenous Nabi 5% Hepatitis B Immune Globulin (Boca HBVIg) Used in Combination With Lamivudine for Patients With Hepatitis B Virus (HBV) Associated Liver Disease Undergoing Liver Transplantation |
|
|
| Completed | 1/2 | 30 | US | Hepatitis B Immune Globulin (Boca HBVIg), Nabi-HB, HepaGam B, Hepatitis B Immune Globulin, HBIG | Biotest Pharmaceuticals Corporation | Hepatitis B Virus Associated Liver Disease | 02/02 | 02/02 | | |
